BEAM-103 clinical trials

This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects

This study is testing a new medicine called BEAM-103 in healthy volunteers to see if it's safe. We'll also check how the body handles the medicine and how it affects blood. It's a first step to understand this potential new treatment.